Generic and Innovative Drugs Market in Central Europe and CIS (Russia, Ukraine and Kazakhstan) countries 2014

on Wednesday, 24 June 2015
ALBANY, NY, June 2015 -- includes new market research report " Generic and Innovative Drugs Market in Central Europe and CIS (Russia, Ukraine and Kazakhstan) countries 2014: Worldwide Industry Size, Shares, Growth, Analysis, Trends And Forecast" to its huge collection of research reports.

Central Europe:

Generic and innovative drugs market in Central Europe, comparative analysis, reimbursement policies and development forecasts for 2014-2018 is a comprehensive guide to the market and all its conditions and variables. This unique report defines and compares market conditions and prospects in each country: Poland, Romania, Bulgaria, Slovakia, the Czech Republic, and Hungary.

This informative publication, prepared by PMR’s experienced team of market analysts, provides and compares all the newest data describing overall market value and specific value and size data for each segment in each country. It examines recent growth using historical and offers detailed forecasts for continued expansion to 2018.

A large portion of the report is dedicated to clarification of regulatory conditions in the generic and innovative drug segments in each country. The text examines current reimbursement procedures and predicted modifications to reimbursement lists and offers a market impact assessment for each. It examines pricing regulations and drug mark up rates, SPCs (supplemental protection certificates), patent expiry periods and data exclusivity regulations and provides VAT rates for these medicines in each market.

CIS Countires (Russia, Ukraine and Kazakhstan):

Discover the value, recent growth and forecasts for expansion in both segments of each market, in each country, and gain valuable and usable information that contributes to a solid working knowledge of this market and its many complex issues.

Learn about key issues in online and mail order sales in recent months and discover how businesses have adjusted to accommodate consumer demand and regulations that apply specifically to this distribution channel.

View report " Generic and Innovative Drugs Market in CIS Countries (Russia, Ukraine and Kazakhstan)" details with TOC at:

This document presents value data for each market segment during the period 2011-2019, analysis of the market share of the overall pharmaceutical sectors in each country occupied by generic and innovative medicines and detailed forecasts for opportunity in 
each of the three countries.

It delves into the pricing and reimbursement processes in each country, covers VAT rates and changes and keeps readers updated on upcoming adjustments to reimbursement schemes. It includes explanations of each country’s regulations with regard to data exclusivity and patent expirations and reviews the impacts of recent changes in other industry regulations on the CIS markets for generic and innovative drugs.

Browse More related reports to "Pharmaceuticals Market" at:

The report includes detailed profiles of the leading manufacturers of these medicines throughout the CIS region that name best-selling products in addition to supplying financial data. It provides input from physicians and patients on the generic and innovative drugs available, including their opinions about purchase and use of these specific types of treatments.

About Us:

ResearchMoz ( ) is the one stop online destination to find and buy market research reports. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. We provide the market context, competitor insight and future trends needed for strategic planning.

For More Information Kindly Contact: 
Mr. Nachiket
Toll Free: 866-997-4948


Post a Comment